CN Patent

CN1905863A — 用于治疗代谢紊乱的方法和组合物

Assigned to Biomarin Pharmaceutical Inc · Expires 2007-01-31 · 19y expired

What this patent protects

本发明涉及一种在高苯丙氨酸血症中用于治疗性干预的新方法和组合物。更具体而言，本说明书描述了使用含有BH4的组合物来治疗各种类型苯丙酮尿症的方法和组合物。BH4与其它治疗方案的联合治疗也在预期中。

USPTO Abstract

本发明涉及一种在高苯丙氨酸血症中用于治疗性干预的新方法和组合物。更具体而言，本说明书描述了使用含有BH4的组合物来治疗各种类型苯丙酮尿症的方法和组合物。BH4与其它治疗方案的联合治疗也在预期中。

Drugs covered by this patent

Patent Metadata

Patent number
CN1905863A
Jurisdiction
CN
Classification
—
Expires
2007-01-31
Drug substance claim
No
Drug product claim
No
Assignee
Biomarin Pharmaceutical Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.